» Articles » PMID: 31255282

Potential Anti-neuroblastoma Agents from Juniperus Oblonga

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2019 Jul 1
PMID 31255282
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma (NB) is a neuroendocrine tumor derived from neural crest cells. Approximately 90% of cases occur in children less than 5 years old. The amplification of MYCN correlates with high-risk neuroblastoma and patients with MYCN amplified showed poorer prognosis than those without MYCN amplification. In this study, three compounds isolated from Juniperus oblonga showed anti-proliferative activity against NB cell lines with and without tetracycline inducible MYCN over-expression which were identified as (-)-deoxypodophyllotoxin (1), (-)-matairesinol (2) and (+)-isocupressic acid (3). The effects of compounds 2 and 3 in NB cells included a decrease in NB cell viability and induction of apoptosis. Compound 1 was more effective in NB cells over-expressing MycN. Compound 1 also showed almost 2-fold induction of intracellular free calcium levels in M2(+) cells, which may indicate a different mechanism of action for this compound. Cytotoxicity studies against the human embryonic kidney cell (HEK-293) showed compounds 1, 2 and 3 were ineffective in the non-cancer cells at concentrations approximating their IC against the NB cell lines. These results may lead to safer and more effective treatment options for NB patients especially for those with high-risk NB.

Citing Articles

Lactoferrin inhibits the proliferation of IMR‑32 neuroblastoma cells even under X‑rays.

Kato S Med Int (Lond). 2023; 3(4):33.

PMID: 37448769 PMC: 10336960. DOI: 10.3892/mi.2023.93.


Potential Benefits of Dietary Plant Compounds on Normal and Tumor Brain Cells in Humans: In Silico and In Vitro Approaches.

Pirvu L, Neagu G, Albulescu A, Stefaniu A, Pintilie L Int J Mol Sci. 2023; 24(8).

PMID: 37108565 PMC: 10139435. DOI: 10.3390/ijms24087404.

References
1.
Cohn S, Pearson A, London W, Monclair T, Ambros P, Brodeur G . The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2008; 27(2):289-97. PMC: 2650388. DOI: 10.1200/JCO.2008.16.6785. View

2.
Brodeur G, Seeger R, Schwab M, Varmus H, Bishop J . Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984; 224(4653):1121-4. DOI: 10.1126/science.6719137. View

3.
Castel V, Segura V, Berlanga P . Emerging drugs for neuroblastoma. Expert Opin Emerg Drugs. 2013; 18(2):155-71. DOI: 10.1517/14728214.2013.796927. View

4.
Pugh T, Morozova O, Attiyeh E, Asgharzadeh S, Wei J, Auclair D . The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013; 45(3):279-84. PMC: 3682833. DOI: 10.1038/ng.2529. View

5.
Pisarev D, Novikov O, Novikova M, Zhilyakova E . Flavonoid composition of Juniperus oblonga Bieb. Bull Exp Biol Med. 2012; 150(6):714-7. DOI: 10.1007/s10517-011-1231-1. View